Halozyme Therapeutics (NASDAQ:HALO) Price Target Raised to $115.00

Дата публикации: 10-08-2026 06:00:47

Halozyme Therapeutics (NASDAQ:HALO – Free Report) had its price objective boosted by HC Wainwright from $95.00 to $115.00 in a research report released on Friday,Benzinga reports. HC Wainwright currently has a buy rating on the biopharmaceutical company’s stock. Other equities research analysts have also issued reports about the company. UBS Group reaffirmed a “buy” rating […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Haemonetics (NYSE:HAE) Price Target Raised to $86.00	0	14.69	10-08-2026
2	Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $146.00	0	14.22	10-08-2026
3	Arlo Technologies (NYSE:ARLO) Price Target Raised to $18.00	0	10.44	10-08-2026
4	Roivant Sciences (NASDAQ:ROIV) Price Target Raised to $42.00	0	11.84	10-08-2026
5	Block (NYSE:XYZ) Price Target Raised to $125.00	0	13.75	10-08-2026
6	AMN Healthcare Services (NYSE:AMN) Price Target Raised to $35.00	0	10.79	10-08-2026
7	Truist Financial Cuts Albemarle (NYSE:ALB) Price Target to $225.00	0	11.13	10-08-2026
8	FY2029 Earnings Forecast for IN8bio Issued By HC Wainwright	0	14.81	10-08-2026
9	Агидель: Ночь 20 дек, Чт	0	0	19-12-2018
10	Газинский: сборная России в матче против шведов будет играть только на победу	0	0	19-11-2018

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 11.48. Источник: www.americanbankingnews.com.